This technology describes a carbon nanofiber and its manufacturing method, where a sacrificial layer is applied to carbon nanofibers composed of multiple carbon nanotubes, followed by laser irradiation.
Carbon nanofibers have had limitations of lower tensile strength and thermal conductivity compared to single carbon nanotubes.
This technology improves tensile strength, elastic modulus, and electrical and thermal conductivity by inducing plastic deformation in carbon nanotubes through laser irradiation.
This technology describes a fire-safe exhaust system designed to purify high-temperature emissions from fire and explosion tests, incorporating wet, dry, and preheating units.
Existing fire test exhaust systems suffered from inefficiencies and limitations, including high pressure loss, increased power consumption, and incomplete removal of pollutants such as sparks and toxic gases.
To address these issues, this technology primarily removes sparks and water-soluble pollutants through wet treatment and utilizes waste heat to remove moisture. This prevents performance degradation of the dry treatment unit and ensures safe exhaust that meets air pollution emission standards.
This technology relates to a novel cis-aconitate synthase variant and a recombinant microorganism for itaconic acid production incorporating the same.
Microbial production of itaconic acid has faced challenges in increasing productivity and yield due to limitations in existing metabolic pathways.
This technology utilizes a novel enzyme to establish an itaconic acid-specific carbon flux, separate from the existing TCA cycle, thereby significantly increasing productivity and yield. It can be applied in the synthetic resin, latex, and food additive industries.
This technology describes a bacteria-based multifunctional microrobot that moves via self-propulsion, achieved by self-assembling bacteria and target substances onto micro liquid crystal droplets containing phase defects.
Conventional microrobots had limited functionality due to complex manufacturing processes and limitations in precise actuation control.
This technology combines antibody-antigen reaction-based adhesive microparticles with self-propelling bacteria, enabling highly reliable functions such as drug detection and release even in unstructured environments.
This technology presents a composition for the prevention, treatment, or improvement of viral infectious diseases, which includes a complex of an ER stress inhibitor and a reactive oxygen species scavenger as its active ingredients.
Existing vaccines are specific to particular viruses, necessitating new development with every emergence of novel viruses or mutations.
This technology works by counteracting the mechanism through which viruses proliferate by inducing oxidative damage to host cells. As it can inhibit the proliferation of most viruses regardless of their type or mutation, it can be utilized as a quasi-universal infection inhibitor/therapeutic agent and a disease control adjuvant.
This technology relates to a pharmaceutical, food, health functional food, or feed composition for the prevention, improvement, or treatment of sarcopenia, comprising mealworm larval protein or its hydrolysate as an active ingredient.
While muscle function decline and muscle loss significantly reduce quality of life, there have been limited materials capable of safely inhibiting muscle loss with long-term intake.
The mealworm larval protein in this technology effectively inhibits myostatin expression, a key factor in muscle loss, allowing it to be widely utilized as a material for addressing muscle diseases in various industries, including pharmaceuticals, food, and feed.
This technology describes a preservative composition that combines additional ingredients with tocopherol to inhibit changes in soluble solids, reducing sugars, pH, and total phenol content in raw or roasted coffee beans and spent coffee grounds.
Existing organic acid and chemically synthesized preservatives had limited preservation effects and posed potential health risks to humans.
To address this, the technology combines tocopherol with ingredients such as propyl gallate, butyl gallate, and ascorbic acid, making it safer than synthetic preservatives while enhancing coffee preservation.
This technology relates to a composition for diagnosing diabetes and a method for providing information, which includes a substance for detecting specific metabolites in the tears of diabetic patients.
Existing diabetes diagnosis relies on invasive methods such as blood sampling, which has caused inconvenience for early and self-diagnosis. Consequently, there has been a demand for simple and non-invasive diagnostic tools.
This technology identifies tear metabolite biomarkers through GC/TOF MS analysis, showing an increase in threonine, mannose, sorbitol, etc., and a decrease in 1,5-anhydroglucitol, beta-alanine, etc. This enables accurate and non-invasive diagnosis of diabetes using only tears.
This technology describes a cell culture device and system comprising multiple upper chambers with porous membranes, a lower chamber, and a support, designed to enable material exchange between different culture environments.
Traditional cell culture systems could only investigate one factor at a time, which made it challenging to effectively observe the interactions between multiple factors.
This technology connects the receiving spaces of the multiple upper chambers to the lower chamber's common material exchange area via porous membranes. This design enables systematic analysis and control of interactions between various culture environments and influencing factors.
This technology is a liquid crystal-based chemical sensor composed of a substrate, an organic ionic material layer, and a liquid crystal film on top, enabling highly selective and sensitive detection of specific gases.
Conventional toxic gas sensors had limitations such as high cost, high power consumption, and environmental hazards.
This technology introduces organic ionic materials with a head group that imparts selectivity and a carbon chain and anion that control sensitivity, enabling selective detection of toxic gases in various environments.
This technology is a composition for inducing neuroectodermal differentiation of stem cells, comprising a TGF-β receptor ALK5 inhibitor, a BMP inhibitor, and an endocytosis inhibitor.
While methods for efficiently differentiating stem cells into neuroectoderm are essential for neural cell therapy, conventional methods have shown low efficiency.
This technology promotes neuroectodermal differentiation by treating human embryonic stem cells and induced pluripotent stem cells with three types of inhibitors, and can be provided as a composition or in kit form.
This technology relates to a method for producing plant-based protein, which involves drying and defatting spent coffee grounds, then extracting protein with an alkaline solution, and finally precipitating and recovering it with an acidic solution.
Most spent coffee grounds are discarded, leading to resource waste and environmental problems, such as greenhouse gas emissions.
To address this, this technology extracts plant-based protein from discarded spent coffee grounds using acid precipitation, thereby utilizing it as a raw material for various food and cosmetic products and enhancing sustainability and resource reusability.
This technology relates to a composition for diagnosing diabetes and a method for providing information, which includes a substance for detecting specific metabolites in the tears of diabetic patients.
Conventional diabetes diagnosis relies on invasive methods such as blood sampling, causing inconvenience for early and self-diagnosis. Consequently, there has been a demand for simple and non-invasive diagnostic tools.
This technology identifies tear metabolite biomarkers through GC/TOF MS analysis, showing increased levels of threonine, mannose, sorbitol, etc., and decreased levels of 1,5-anhydroglucitol, beta-alanine, etc. This enables accurate and non-invasive diagnosis of diabetes using only tears.
This technology concerns a composition for diagnosing diabetes and a method for providing information, which includes a substance that detects specific metabolites in the tears of diabetic patients.
Existing diabetes diagnosis relies on invasive methods such as blood sampling, which has caused inconvenience for early and self-diagnosis. Consequently, there has been a demand for simple and non-invasive diagnostic tools.
This technology, through GC/TOF MS analysis, identifies tear metabolite biomarkers where threonine, mannose, sorbitol, and others increase, while 1,5-anhydroglucitol, beta-alanine, and others decrease, thereby enabling accurate and non-invasive diagnosis of diabetes using only tears.
This technology relates to tofu for preventing and improving muscle diseases, which contains mealworm larva protein or its extracts/hydrolysates as active ingredients.
With an aging population, diseases related to sarcopenia and muscle atrophy are increasing. However, there has been a lack of food products that improve muscle function decline while being easy to consume.
This tofu effectively suppresses the expression of muscle-wasting genes such as myostatin, MuRF1, and Atrogin-1. It also exhibits excellent antioxidant and anti-inflammatory activity. Its low gel strength and high digestibility make it useful as a customized functional food for the elderly or patients with chewing and swallowing difficulties.
